Contact Us

DESTINATION NEWS

Datasea's New 5G AI Multimodal Agreements Have Already Generated $9.0 Million of 5G-AI Services

Sep 18, 2024

Agreements Boost Fiscal 2025 Revenue and Expand Datasea\'s 5G Application Market Positioning in China

Frost & Sullivan Recognizes Keysight's Network Packet Brokers with 2024 New Product Innovation Award

Sep 18, 2024

Keysight delivers scalable,high-performance,and highly flexible network visibility solutions for efficient network monitoring,threat detection,analysis and response

Innovent Announces Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Combined with Bevacizumab in Advanced Colorectal Cancer at the 2024 ESMO Congress

Sep 18, 2024

SAN FRANCISCOand SUZHOU,China,Sept. 18,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qu

Runergy Unveils Award-Winning Solar Innovations at RE+ 2024

Sep 18, 2024

ANAHEIM,Calif.,Sept. 18,2024-- Runergy,a leading solar energy company,showcased its cutting-edge photovoltaic (PV) modules at RE+ 2024,North America\'s premier solar energy exhibition held at the Anah

Fruit Attraction celebrates the largest edition in its history positioning Madrid as the global epicenter of the fruit and vegetable industry

Sep 18, 2024

MADRID,Sept. 18,2024-- From8 to 10 October,Fruit Attraction will be hosting its 16th edition with a great line-up of activities,consolidating itself as the benchmark event for the sector on a global

Senhwa Biosciences Announces IND Submission to US FDA for Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors sponsored by NCI

Sep 18, 2024

TAIPEI and SAN DIEGO,Sept. 18,2024-- Senhwa Biosciences,Inc. (TPEx: 6492),a drug development company focusing on first-in-class therapeutics for oncology,rare diseases,and infectious diseases,today a

1 ... 235 236 237 238 239 240 241 ... 318